BTIG Maintains Buy on DexCom, Raises Price Target to $110

BTIG analyst Marie Thibault maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $92 to $110.

BTIG analyst Marie Thibault maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $92 to $110.

Total
0
Shares
Related Posts